Senores Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	4,559	3,983	2,145	353.37	141.7
Revenue Growth (YoY)	1190.01%	85.65%	507.07%	149.38%	-
Cost of Revenue	2,074	1,874	1,089	127.96	80.75
Gross Profit	2,484	2,108	1,057	225.41	60.95
Selling, General & Admin	699.9	636	363.1	51.75	28.92
Other Operating Expenses	758.6	575.1	277.5	46.93	12.51
Operating Expenses	1,652	1,380	740.8	116.47	48.48
Operating Income	832.5	728.8	315.8	108.94	12.47
Interest Expense	-217.7	-203.7	-85	-18.37	-5.1
Interest & Investment Income	-	71.6	4.6	0.39	1.93
Currency Exchange Gain (Loss)	-	34	10.7	34.21	2.68
Other Non Operating Income (Expenses)	221.1	75.2	3.6	-0.77	-0.55
EBT Excluding Unusual Items	835.9	705.9	249.7	124.4	11.43
Gain (Loss) on Sale of Assets	-	-0.2	-0.3	-0.03	-
Pretax Income	835.9	705.7	249.4	124.37	11.43
Income Tax Expense	149.8	122.3	-77.6	40.04	1.52
Earnings From Continuing Operations	686.1	583.4	327	84.33	9.91
Minority Interest in Earnings	-10.5	2.2	-12.5	-	-
Net Income	675.6	585.6	314.5	84.33	9.91
Net Income to Common	675.6	585.6	314.5	84.33	9.91
Net Income Growth	701.14%	86.20%	272.94%	750.96%	-
Shares Outstanding (Basic)	39	36	23	10	5
Shares Outstanding (Diluted)	39	36	26	13	5
Shares Change (YoY)	208.55%	41.13%	103.16%	131.33%	-
EPS (Basic)	17.26	16.10	13.67	8.87	1.81
EPS (Diluted)	17.26	16.10	12.21	6.65	1.81
EPS Growth	159.58%	31.88%	83.61%	267.92%	-
Free Cash Flow	-	-2,034	-775.3	-483.56	-211.29
Free Cash Flow Per Share	-	-55.94	-30.09	-38.12	-38.53
Gross Margin	54.49%	52.94%	49.25%	63.79%	43.01%
Operating Margin	18.26%	18.30%	14.72%	30.83%	8.80%
Profit Margin	14.82%	14.70%	14.66%	23.86%	6.99%
Free Cash Flow Margin	-	-51.08%	-36.14%	-136.84%	-149.11%
EBITDA	1,027	882.4	404.8	109.55	12.61
EBITDA Margin	22.53%	22.16%	18.87%	31.00%	8.90%
D&A For EBITDA	194.59	153.6	89	0.61	0.14
EBIT	832.5	728.8	315.8	108.94	12.47
EBIT Margin	18.26%	18.30%	14.72%	30.83%	8.80%
Effective Tax Rate	17.92%	17.33%	-	32.19%	13.30%
Revenue as Reported	4,780	4,175	2,173	390.21	146.31
Advertising Expenses	-	32.3	8.5	3.82	0.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.